June rush drives near-record quarter for biotech flotations
Biotech IPOs raised a huge $2.3bn on Western exchanges in the second-quarter of 2018, as private companies rushed to market ahead of the summer lull.
Venture financing still positive but big rounds less common
The trend for VCs to pile in to bigger, later rounds might just be weakening.
